3Martino R,Subira M.Invasive fungai infections in hematology: new trends. Ann Hematol. 2002 May;81(5)2233-43.Epub 2002 May 4. 被引量：1
4Chamilos G, Kontoyiannis DP. The rationale of combination antifungal therapy in severely immunocompromised patients:empiricism versus evidence-based medicine.Curt Opin Infect Dis. 2006 Aug；19(4):380-385. 被引量：1
5Leather HL, Wingard JR. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Blood Rev,2006 Jun 13；[Epub ahead of print]. 被引量：1
3Mermel LA, Maki DG. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med, 1993,119(4) :270-272. 被引量：1
7MATTIUZZI G N,ESTEY E,RAAD I,et al.Liposomal amphotericin B versus the combination of fluconazole and itraeonazole as prophylaxis for invasive fun infactions during induction chemotherapy for patients with zcute myelogenous leukemia and myelodysplastic syndrome[J].Cancer,2003,97:450-456. 被引量：1
8DAS S,SHIVAPRAKASH M R,CHAKRABARTI A.New antifungal agents in pediatric practice[J].Indian Pediatr,2009,46:225-231. 被引量：1
9CHANDRASEKAR P H,CUTRIGHT J,MANAVATHU E.Efficacy of voriconazole against invasive pulmonary aspergilloisis in a guinea-pig model[J].J Antimicrob Chemother,2002,45:673-676. 被引量：1
